(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CTTQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

CTTQ

ST13

US500000079159365

Class

5

Filing

79159365

Registration

4853289

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

48

Latest update

03/02/2026

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

11/11/2014

Registration date

11/17/2015

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/01/2025

Last transaction

03/02/2026

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Lianyungang City, CN

Examiner

ROSSMAN, WILLIAM M

Current location

Historical data usage

Mark description

The mark consists of four stylized Latin characters "C", "T", "T", "Q".

Holders and representatives

Holders

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Representatives

Alexander Lazouski Lazouski IP LLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicines for human purposes for the treatment of hepatopathyendocrine diseasemalnutritionurinary system diseasestumourrespiratory diseaseinfectious diseaseallergycardiovascular and cerebrovascular diseasesdiabetes; tonics medicines for the treatment of malnutrition; vitamin preparations; medicinal drinks; cod liver oil; lecithin for medical purposes; royal jelly for pharmaceutical purposes; disinfectants for hygiene purposes; sanitary sterilizing preparations; media for bacteriological cultures

Publications

History of USPTO decisions and trademark events.

48 publications found

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

03/01/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/29/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

07/01/2025

71AG

REGISTERED-SEC.71 ACCEPTED

07/01/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/30/2025

ES71

TEAS SECTION 71 RECEIVED

03/27/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

11/18/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/15/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/03/2024

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/03/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

11/28/2021

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

11/02/2021

XXCR

GENERIC MADRID TRANSACTION CREATED

11/02/2021

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

10/05/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/05/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/05/2021

71AG

REGISTERED-SEC.71 ACCEPTED

02/05/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/05/2021

ES71

TEAS SECTION 71 RECEIVED

12/23/2020

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/17/2020

IRRH

IRREGULARITY FROM IB EXAMINED BY MPU

06/30/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/26/2017

IRFI

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

10/14/2016

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

05/31/2016

XXCR

GENERIC MADRID TRANSACTION CREATED

05/31/2016

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/17/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

11/17/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/01/2015

PUBO

PUBLISHED FOR OPPOSITION

09/01/2015

GPNX

NOTIFICATION PROCESSED BY IB

08/28/2015

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/12/2015

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/12/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/12/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/25/2015

ALIE

ASSIGNED TO LIE

07/25/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/14/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/14/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/14/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/14/2015

RFNT

REFUSAL PROCESSED BY IB

04/04/2015

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/13/2015

RFRR

REFUSAL PROCESSED BY MPU

03/13/2015

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/13/2015

CNRT

NON-FINAL ACTION WRITTEN

03/12/2015

DOCK

ASSIGNED TO EXAMINER

03/03/2015

MAFR

APPLICATION FILING RECEIPT MAILED

02/07/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/03/2015

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/29/2015

Continuous trademark protection

Get notified about every new filing that threatens CTTQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.